BACKGROUND: Neuroticism is a psychological construct that includes tendency to exhibit negative affect (NA), having poor stress tolerance and being at risk for depression and anxiety disorders. The consequences of neuroticism in the elderly adults are understudied. We hypothesized that older depressed patients with comorbid neuroticism at baseline would have worse mood and cognitive outcomes compared with older depressed patients without neuroticism. METHODS: One hundred and ten older depressed adults completed baseline self-reports of depression and the NEO-Personality Inventory as a measure of neuroticism, were administered a battery of cognitive tests annually and were seen by a study psychiatrist who assessed patients using the Montgomery Åsberg Depression Rating Scale (MADRS) and treated patients with antidepressants using an established treatment guideline. Patients were followed as clinically indicated for up to three years. We measured remission (defined as MADRS score ≤ 6) rates at one year as a categorical outcome. In addition, we used Cox proportional hazard models to examine the relationship between neuroticism and change in MADRS and cognitive score over time. RESULTS: Non-remitters (30%) at one year had higher scores in total neuroticism (TN), vulnerability to stress (VS), and NA. Over three years, time to achieve remission was associated with higher TN, higher VS, and greater NA. In analyses controlling for baseline cognitive score, age, sex, and education, VS was associated with baseline to two-year change in cognition. CONCLUSIONS: Presence of neuroticism in older depressed patients treated with medication is associated with poor mood outcomes and may indicate increased risk of cognitive decline.
BACKGROUND: Neuroticism is a psychological construct that includes tendency to exhibit negative affect (NA), having poor stress tolerance and being at risk for depression and anxiety disorders. The consequences of neuroticism in the elderly adults are understudied. We hypothesized that older depressedpatients with comorbid neuroticism at baseline would have worse mood and cognitive outcomes compared with older depressedpatients without neuroticism. METHODS: One hundred and ten older depressed adults completed baseline self-reports of depression and the NEO-Personality Inventory as a measure of neuroticism, were administered a battery of cognitive tests annually and were seen by a study psychiatrist who assessed patients using the Montgomery Åsberg Depression Rating Scale (MADRS) and treated patients with antidepressants using an established treatment guideline. Patients were followed as clinically indicated for up to three years. We measured remission (defined as MADRS score ≤ 6) rates at one year as a categorical outcome. In addition, we used Cox proportional hazard models to examine the relationship between neuroticism and change in MADRS and cognitive score over time. RESULTS: Non-remitters (30%) at one year had higher scores in total neuroticism (TN), vulnerability to stress (VS), and NA. Over three years, time to achieve remission was associated with higher TN, higher VS, and greater NA. In analyses controlling for baseline cognitive score, age, sex, and education, VS was associated with baseline to two-year change in cognition. CONCLUSIONS: Presence of neuroticism in older depressedpatients treated with medication is associated with poor mood outcomes and may indicate increased risk of cognitive decline.
Authors: Marko Jelicic; Hans Bosma; Rudolf W H M Ponds; Martin P J Van Boxtel; Peter J Houx; Jelle Jolles Journal: Exp Aging Res Date: 2003 Jan-Mar Impact factor: 1.645
Authors: Timothy Petersen; George I Papakostas; Kathryn Bottonari; Brian Iacoviello; Jonathan E Alpert; Maurizio Fava; Andrew A Nierenberg Journal: Psychiatry Res Date: 2002-01-31 Impact factor: 3.222
Authors: Robert S Wilson; David A Bennett; Carlos F Mendes de Leon; Julia L Bienias; Martha C Morris; Denis A Evans Journal: Psychoneuroendocrinology Date: 2005-01 Impact factor: 4.905
Authors: J C Morris; A Heyman; R C Mohs; J P Hughes; G van Belle; G Fillenbaum; E D Mellits; C Clark Journal: Neurology Date: 1989-09 Impact factor: 9.910
Authors: David C Steffens; Kevin J Manning; Rong Wu; James J Grady; Richard H Fortinsky; Howard A Tennen Journal: Int Psychogeriatr Date: 2015-09-01 Impact factor: 3.878
Authors: Anne D Johnson; Douglas R McQuoid; David C Steffens; Martha E Payne; John L Beyer; Warren D Taylor Journal: Int J Geriatr Psychiatry Date: 2016-12-28 Impact factor: 3.485
Authors: Joey Ward; Nicholas Graham; Rona J Strawbridge; Amy Ferguson; Gregory Jenkins; Wenan Chen; Karen Hodgson; Mark Frye; Richard Weinshilboum; Rudolf Uher; Cathryn M Lewis; Joanna Biernacka; Daniel J Smith Journal: PLoS One Date: 2018-09-21 Impact factor: 3.240